HEOR News Roundup

Tuesday, August 27, 2019 | Issue 466

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

Former FDA Commissioners Encourage
Expanded Use of RWE, RWD

Three former FDA chiefs have called on officials to expand the use of RWE and RWD to not only bolster the foundation of evidence for new therapies, but also as a way to drive down health care costs.

Read More

NICE Chief Dillon to Exit in 2020

How Do PCORI-Funded Studies Align with Mission?

Is Price Transparency All It’s Cracked Up to Be?

Specialty Drugs Hit 40% of Employer Spending Last Year




Identifying Evidence for NICE Economic Submissions

September 5 | York, England




Integrating Innovative Genetic Testing Into the Pharmacy Decision-Making Process

August 29

Syndicated Reports
Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026
Biosimilars: US Payer Insights (2019)
White Papers
Social Determinants of Health: The Impact on Members, Health Outcomes and the Bottom Line
Leveraging Technology to Reduce Costs in Clinical Trials
  Head of Health Economic Modelling Associate Research Director (PS24632) Market Access Writer 1 (Entry Level) London Entry-Level Market Access Communications Writer  

Share this newsletter!